Parapoxviruses are strongly inhibited in vitro by cidofovir (Q40829323)

24 September 2017

title

Parapoxviruses are strongly inhibited in vitro by cidofovir (English)

1 reference

24 September 2017

P F Nettleton

1

1 reference

24 September 2017

J A Gilray

series ordinal

2

1 reference

24 September 2017

H W Reid

series ordinal

3

1 reference

24 September 2017

A A Mercer

series ordinal

4

1 reference

24 September 2017

publication date

1 December 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

48

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

205-208

1 reference

Characteristics of orf in a farming community in mid-Wales

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Recurrent contagious ecthyma (Orf) in an immunocompromised host successfully treated with cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Parapoxvirus infections of Reindeer and Musk Ox associated with unusual human infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

A case of human orf in an immunocompromised patient treated successfully with cidofovir cream

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

The reactivity of monoclonal antibodies against orf virus with other parapoxviruses and the identification of a 39 kDa immunodominant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Bullous pemphigoid complicating human orf

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Giant parapox infection in a two year old child

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Parapoxvirus infections acquired after exposure to wildlife

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

Immune responses of patients to orf virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2800%2900130-3

7 January 2021

10.1016/S0166-3542(00)00130-3

Identifiers

DOI

1 reference

24 September 2017

1 reference